Pro 2012-007 (Jianfeng Group's Announcement on Subsidiary Guarantee)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2012-007
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Guarantees to Subsidiaries
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Important Content Reminder
● Name of Guarantor: Daye Jianfeng Cement Co., Ltd., Zhejiang Jianfeng Pharmaceutical Co., Ltd., Jinhua Pharmaceutical Co., Ltd., Zhejiang Jianfeng International Trade Co., Ltd., Yunnan Jianfeng Cement Co., Ltd.
● Proposed guarantee amount: this time the guarantee amount is 0.73 billion yuan.
● Is there any counter-guarantee in this guarantee: No
● As of the date of this disclosure, the balance of the company's external guarantee: 348.8 million yuan
● Cumulative quantity of overdue external guarantee: No
Overview of 1. guarantee
April 6, 2012, zhejiang Jianfeng Group Co., Ltd. held the fourth meeting of the eighth session of the board of directors. The meeting should have nine directors, actually nine, in line with the relevant provisions of the Company Law and the articles of Association, and the resolutions made are legal and effective. The meeting was presided over by Chairman Jiang Xiaomeng. After deliberation and voting, the company guarantee proposal was deliberated and passed with 9 votes in favor, 0 against and 0 abstention.
Basic Information of the Guaranteed 2.
1. Daye Jianfeng Cement Co., Ltd. has a registered capital of 0.25 billion yuan, of which the Company accounts for 6% and Zhejiang Jianfeng Cement Co., Ltd. (93.91 held by the Company) accounts for 70%. registered address: daye city of hubei province; main business: production and sales of cement, clinker etc.
2, Zhejiang Jianfeng Pharmaceutical Co., Ltd., with a registered capital of 149.07 million yuan, of which: the company accounts for 99.16, registered address: Jinhua City, Zhejiang Province, mainly engaged in: tablets, capsules, granules, bulk drugs, etc. .
, Jinhua Pharmaceutical Co., Ltd., with a registered capital of 22 million yuan, of which: the company's holding subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. accounted for 90%, the company accounted for 10%, registered address: Jinhua City, Zhejiang Province; Main business: wholesale and retail of Chinese medicinal materials, Chinese patent medicines, biochemical drugs, etc.
, Zhejiang Jianfeng International Trade Co., Ltd., with a registered capital of 20 million yuan, of which: 90% of the company and 10% of Jianfeng Pharmaceutical Co., Ltd., registered address: Jinhua City, Zhejiang Province, mainly engaged in: cargo storage, domestic trade, etc. .
. Yunnan Jianfeng Cement Co., Ltd. has a registered capital of 0.15 billion yuan, of which 75% is the company and 25% is the holding subsidiary Jianfeng Cement (93.91 held by the company). Its registered address is 43 kilometers away from Silan Highway, Liushun Township, Simao District, Pu 'er City, Yunnan Province. Its main business is cement production and sales , etc.
Main Financial Data of the above Subsidiaries in 2011 (Unit: ten thousand yuan)
company name |
total assets |
total liabilities |
total operating income |
net profit |
Daye Jianfeng Cement Co., Ltd. |
82,281.39 |
43,175.50 |
68,534.79 |
13,673.23 |
Zhejiang Jianfeng Pharmaceutical Co., Ltd. |
.53 |
38,875.82 |
76,841.38 |
3,250.77 |
Jinhua Pharmaceutical Co., Ltd. |
20,701.94 |
,922.17 |
52,146.97 |
534.80 |
Yunnan Jianfeng Cement Co., Ltd. |
28,807.42 |
14,402.18 |
4,214.21 |
-594.76 |
Zhejiang Jianfeng International Trade Co., Ltd. |
72,60.13 |
6,254.75 |
10,002.48 |
-72.84 |
III. Main Contents of Guarantee
1. To provide guarantee for loans from financial institutions by holding subsidiaries, the following limits are set:
guaranteed unit |
this set guarantee amount (ten thousand yuan) |
daye peak cement co., ltd. |
30000 |
Zhejiang Jianfeng Pharmaceutical Co., Ltd. |
20000 |
Jinhua Pharmaceutical Co., Ltd. |
2000 |
Zhejiang Jianfeng International Trade Co., Ltd. |
1000 |
Yunnan Jianfeng Cement Co., Ltd. |
20000 |
Total |
73000 |
2, Agree to provide guarantee letter for 342 Zhejiang Jianfeng International Trading Co., Ltd., provide corresponding guarantee for the goods stored in the company by the customers of Zhejiang Jianfeng International Trade Co., Ltd.
The guarantee within the above amount is authorized to be executed by the chairman of the board of directors.
above matters shall be submitted to the shareholders' meeting for deliberation.
4. the opinion of the board of directors
The above guaranteed companies are all controlling subsidiaries of the company. The company can effectively control the guarantee risks, and the board of directors agrees to the above guarantees.
5. Cumulative Number of External Guarantees and Number of Overdue Guarantees
As of the date of this disclosure, the balance of the Company's external guarantees is 348.8 million yuan. No overdue guarantee.
Catalogue of 6. Documents for Reference
1 , Resolution of the Fourth Meeting of the Eighth Board of Directors of the Company;
2 , photocopy of the guaranteed person's business license;
hereby announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
April 6, 2012
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page